Cancer morbidity and mortality rates remain high, and thus, at present, considerable efforts are focused on finding drugs with higher sensitivity against tumor cells and fewer side effects. Disulfiram...
Evidence suggests people who inject drugs (PWID) prescribed opioid agonist treatment (OAT) are less likely to provide injection drug use (IDU) initiation assistance. We investigated the association between OAT...
The opioid crisis is a major public health challenge in the United States, killing about 70,000 people in 2020 alone. Long delays and feedbacks between policy actions and their effects on drug-use behavior create dynamic...
Abstrait
Importance Il est nécessaire d’adapter les traitements aux patients les plus susceptibles d’en tirer le plus grand bénéfice afin d’améliorer les résultats pour les patients et d’accroître la rentabilité des traitements...
Importance Patients who use cannabis for medical reasons may benefit from discussions with clinicians about health risks of cannabis and evidence-based treatment alternatives. However, little is known about the prevalence of...
Proper guidelines for professionals are essential in providing quality services. With this in mind, Dhaka Ahsania Mission Health Sector organized a day-long consultation workshop on June 2, 2022, under the JPRPHRPC project supported by GIZ...
To improve the quality of drug treatment and rehabilitation services, for the third time, the Government of Bangladesh has provided grants to private drug treatment and rehabilitation centers across the country.
Moreover, the government...
Importance Les cigarettes électroniques nonnicoliques contiennent des produits chimiques, des arômes et des solvants qui ont des effets nocifs connus sur la santé et / ou qui n’ont pas été prouvés sûrs pour l’inhalation.
Objecti...
Substance use among youth (ages 12–24) is troublesome given the increasing risk of harms associated. Even more so, substance use services are largely under utilised among youth, most only accessing support when in crisis. Few...
Recently developed buprenorphine depot injections have the potential to reduce risk for diversion and misuse, and to increase adherence with fewer visits for supervised intake. However, it is unclear how patients perceive this...
